Complement Deposition and Cell Death after Myoblast Transplantation

by Daniel Skuk, Jacques P. Tremblay Ph.D.
Published 1998-09-01

De Novo Circulating Antidonor's Cell Antibodies During Induced Acute Rejection of Allogeneic Myofibers in Myogenic Cell Transplantation: A Study in Nonhuman Primates

by Daniel Skuk, MD, Jacques P. Tremblay, PhD
Published 2017-12-01

Administration of a Soluble Activin Type IIB Receptor Promotes the Transplantation of Human Myoblasts in Dystrophic Mice

by Raouia Fakhfakh, Se-Jin Lee, Jacques P. Tremblay Ph.D.
Published 2012-07-01

Losartan Enhances the Success of Myoblast Transplantation

by Raouia Fakhfakh, Yann Lamarre, Daniel Skuk, Jacques P. Tremblay Ph.D.
Published 2012-02-01

AG490 Improves the Survival of Human Myoblasts in Vitro and in Vivo

by Catherine Gérard, Christine Dufour, Sébastien Goudenege, Daniel Skuk, Jacques P. Tremblay Ph.D.
Published 2012-12-01

Fibrin Gel Improves the Survival of Transplanted Myoblasts

by Catherine Gerard, Marie Anne Forest, Genevieve Beauregard, Daniel Skuk, Jacques P. Tremblay Ph.D.
Published 2012-02-01

Dynamics of the Early Immune Cellular Reactions after Myogenic Cell Transplantation

by Daniel Skuk, Nicolas Caron, Marlyne Goulet, Brigitte Roy, Francisco Espinosa, Jacques P. Tremblay Ph.D.
Published 2002-10-01

Dystrophin Expression following the Transplantation of Normal Muscle Precursor Cells Protects mdx Muscle from Contraction-Induced Damage

by Joel Rousseau, Nicolas Dumont, Carl Lebel, Simon P. Quenneville, Claude H. Côté, Jérome Frenette, Jacques P. Tremblay Ph.D.
Published 2010-05-01